Advertisement
Advertisement
NNVC
NanoViricides Inc.
1.55
USDSponsored
+0.13
+9.15%
May 08, 16:00 UTC -4
Closed
After-Market
1.55
0.00
+0.32%
NNVC Earnings Reports
Positive Surprise Ratio
NNVC beat 13 of 14 last estimates.
93%
Next Report
In 3 Days
Date of Next Report
May 13, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.13
Implied change from Q2 26 (Revenue/ EPS)
--
/+18.18%
Implied change from Q3 25 (Revenue/ EPS)
--
/--
NanoViricides Inc. earnings per share and revenue
On Feb 17, 2026, NNVC reported earnings of -0.11 USD per share (EPS) for Q2 26, beating the estimate of -0.14 USD, resulting in a 22.97% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.97% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analysts forecast an EPS of -0.13 USD, with revenue projected to reach -- USD, implying an increase of 18.18% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Quoin Pharmaceuticals, Ltd. - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.96
Actual
-$1.77
Surprise
+9.93%
ZOETIS INC.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.63
Actual
$1.53
Surprise
-6.19%
Stevanato Group S.p.A.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.10
Actual
$0.11
Surprise
+5.45%
Crinetics Pharmaceuticals, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.26
Actual
-$1.23
Surprise
+2.51%
NewAmsterdam Pharma Company N.V. Ordinary Shares
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.50
Actual
-$0.40
Surprise
+20.32%
Collegium Pharmaceutical, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$1.62
Actual
$1.76
Surprise
+8.43%
Xeris Biopharma Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+296.08%
Ironwood Pharmaceuticals, Inc. - Class A
Report Date
May 07, 2026 For Q1 26
Estimate
$0.24
Actual
$0.24
Surprise
-1.96%
SIGA Technologies Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
Profound Medical Corp. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.25
Actual
-$0.19
Surprise
+25.75%
FAQ
What were NanoViricides Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, NanoViricides Inc. reported EPS of -$0.11, beating estimates by 22.97%, and revenue of $0.00, 0% as expectations.
How did the market react to NanoViricides Inc.'s Q2 2026 earnings?
The stock price moved up 0.97%, changed from $1.03 before the earnings release to $1.04 the day after.
When is NanoViricides Inc. expected to report next?
The next earning report is scheduled for May 13, 2026.
What are the forecasts for NanoViricides Inc.'s next earnings report?
Based on 4
analysts, NanoViricides Inc. is expected to report EPS of -$0.13 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement